Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Neurocrine Biosciences, Inc. (NBIX)

« Back to company index

NBIX Chatter Timeline

Stock Ticker for NBIX

Most Active Tweeters for NBIX

UserTweets
@Tickeron 5
@MarcJacksonLA 5
@newsfilterio 4
@SweepCastApp 4
@FlashAlert_me 4

Recent Tweets for NBIX

fintel_io @fintel_io
Insider Matt Abernethy reports selling 1,645 shares of $NBIX for a total cost of $135,852.49 https://t.co/azHErUbBdv #FNTL
December 3rd 2021, 10:12pm
formwhisperscom @formwhisperscom
#FWSells $NBIX ABERNETHY MATT, Chief Financial Officer of NEUROCRINE BIOSCIENCES INC sold 1,645 shares on 2021-12-0… https://t.co/BrB0oPxmxc
December 3rd 2021, 10:12pm
SwingTradeBot @SwingTradeBot
New 52 Week Low today: $NBIX $JUPW ... https://t.co/0EM4q8YtyQ
December 2nd 2021, 8:12pm
newsfilterio @newsfilterio
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $NBIX https://t.co/gHcqR1Ln2L
December 2nd 2021, 8:12am
newsfilterio @newsfilterio
Onyia Jude (Chief Scientific Officer) acquired new securities, reported in a new form 4 filed with the SEC $NBIX https://t.co/13zslwYYUL
December 2nd 2021, 8:12am
Tickeron @Tickeron
$NBIX's Aroon indicator drops into Downtrend on November 30, 2021. View odds for this and other indicators:… https://t.co/Ww315A8KtT
December 2nd 2021, 5:12am
quantisnow @quantisnow
$NBIX ? SEC Form 4 filed by Onyia Jude https://t.co/hCIpdXl0E4 45 seconds delayed.
December 2nd 2021, 1:12am
FlashAlert_me @FlashAlert_me
$NBIX [15s. delayed] filed SEC form 4: Chief Scientific Officer Onyia Jude: Transacted Derivative Securities betwe… https://t.co/XcgoyhPI0T
December 2nd 2021, 1:12am
TWANewsOfficial @TWANewsOfficial
$NBIX Officer ONYIA Updates Ownership of NEUROCRINE BIOSCIENCES INC (NBIX)
December 2nd 2021, 1:12am
quantisnow @quantisnow
$NBIX ? SEC Form 3 filed by new insider Onyia Jude https://t.co/5UH07H4a0P 45 seconds delayed.
December 2nd 2021, 12:12am
FlashAlert_me @FlashAlert_me
$NBIX [15s. delayed] filed SEC form 3: Chief Scientific Officer Onyia Jude: https://t.co/f9eDjjRfmj
December 2nd 2021, 12:12am
TWANewsOfficial @TWANewsOfficial
$NBIX Officer ONYIA -Initial Statement of Ownership of NEUROCRINE BIOSCIENCES INC (NBIX)
December 2nd 2021, 12:12am
SweepCastApp @SweepCastApp
SweepCast alerted: $NBIX with Unusual Options Activity Alerted on $90 CALL Expiring: 02-18-2022 worth 30K? |? Learn… https://t.co/BeoWAdOy5x
December 1st 2021, 4:12am
newsfilterio @newsfilterio
Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer $NBIX https://t.co/ve7v0Hmq3r
December 1st 2021, 1:12am
mehabecapital @mehabecapital
$NBIX @ 83.25 (-1.76%) : Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer https://t.co/JA54nemgeI
November 30th 2021, 10:11pm
MarcJacksonLA @MarcJacksonLA
$NBIX Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer https://t.co/oQPkROsSMk
November 30th 2021, 9:11pm
MarketCurrents @MarketCurrents
$NBIX - Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer https://t.co/OJvt52uk33
November 30th 2021, 9:11pm
FlashAlert_me @FlashAlert_me
$NBIX [15s. delayed]: Issued Press Release on November 30, 16:05:00: Neurocrine Biosciences Appoints Jude Onyia, Ph… https://t.co/cchFgTe5ah
November 30th 2021, 9:11pm
phasefivebot @phasefivebot
$NBIX Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer https://t.co/xaDahArxQL
November 30th 2021, 9:11pm
algobotnews @algobotnews
Neurocrine names Jude Onyia, Ph.D., as Chief Scientific Officer $NBIX
November 30th 2021, 9:11pm
StockNewsBot2 @StockNewsBot2
$NBIX Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer https://t.co/tfPheKV30d
November 30th 2021, 9:11pm
quantisnow @quantisnow
$NBIX ? Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer https://t.co/Qo8RUk5OIL Th… https://t.co/aYME3FNdnM
November 30th 2021, 9:11pm
stock_titan @stock_titan
$NBIX Neurocrine Biosciences Appoints Jude Onyia, Ph.D., as Chief Scientific Officer https://t.co/AjunXI408T
November 30th 2021, 9:11pm
YouCanFoolMost @YouCanFoolMost
RT @Tickeron: $NBIX enters a Downtrend because Momentum Indicator dropped below the 0 level on November 2, 2021. View odds for this and oth…
November 30th 2021, 7:11pm
Tickeron @Tickeron
$NBIX enters a Downtrend because Momentum Indicator dropped below the 0 level on November 2, 2021. View odds for th… https://t.co/PJLY6MUV90
November 30th 2021, 7:11pm
Tickeron @Tickeron
If you’re trading this week, Read This! $NBIX RSI Indicator left the oversold zone. #NeurocrineBiosciences… https://t.co/P8LZlfdBfX
November 30th 2021, 4:11pm
ShortAlgoTrades @ShortAlgoTrades
$NBIX Awaiting Short Signal. Stock Trading Ideas by https://t.co/jpmUt7T6MX #Investing #trading https://t.co/cHMz9jbrMK
November 30th 2021, 12:11pm
kwhenfinance @kwhenfinance
Neurocrine Biosciences, Inc. Shares Near 52-Week Low - Market Mover https://t.co/jwQIsXmAiM $NBIX #stockmarket #kwhenfinance
November 30th 2021, 9:11am
Tickeron @Tickeron
$NBIX enters a Downtrend as Momentum Indicator dropped below the 0 level on November 2, 2021. View odds for this an… https://t.co/pjZJrI0bT3
November 30th 2021, 4:11am
1anOnlyMary @1anOnlyMary
Neurocrine Biosciences Enters Oversold Territory ( $NBIX) https://t.co/pWpircBWw9
November 29th 2021, 7:11pm
RamUltraAlgo @RamUltraAlgo
Waiting for Short signal on $NBIX https://t.co/SRHwwHgn8E
November 29th 2021, 6:11pm
MarcJacksonLA @MarcJacksonLA
$NBIX Neurocrine Biosciences Enters Oversold Territory (NBIX) | NASDAQ https://t.co/Uqx3GZacTr
November 29th 2021, 6:11pm
LlcBillionaire @LlcBillionaire
Neurocrine Biosciences Enters Oversold Territory ( $NBIX) https://t.co/ik21JMtF1d
November 29th 2021, 5:11pm
humour_humourrr @humour_humourrr
@lblegend33 $NBIX unfortunately is not cool for most biotech gamblers because they are cash flow positive and not <… https://t.co/F3CZMzfzMQ
November 24th 2021, 5:11pm
R5ive8 @R5ive8
@ChimeraResearch Is $PFE buying $NBIX?
November 24th 2021, 5:11pm
lblegend33 @lblegend33
Added $nbix 86s
November 24th 2021, 3:11pm
StckPro @StckPro
$NBIX NEW ARTICLE : Neurocrine Biosciences Gets Promising Drugs in Licensing Deal https://t.co/0V5jMuEzCS Get all t… https://t.co/nOFyDsTwB8
November 24th 2021, 3:11pm
ShogunTrade @ShogunTrade
$NBIX Awaiting buy signal. Trading simplified, free trial at https://t.co/6vnULU2sSf https://t.co/ThHVogn3De
November 24th 2021, 12:11pm
RamUltraAlgo @RamUltraAlgo
Waiting for Buy signal on $NBIX https://t.co/wETMv1UKMq
November 23rd 2021, 6:11pm
Jarvis_Alerts @Jarvis_Alerts
$NBIX 60P Exp:20-May-22 ? ? Total(Day): $50,830 #UnusualActivity Sign-up free for beta ver.:… https://t.co/lyttpIGiuY
November 23rd 2021, 1:11pm
SweepCastApp @SweepCastApp
SweepCast alerted: $NBIX with Unusual Options Activity Alerted on $60 PUT Expiring: 05-20-2022 worth 51K? |? See more in profile
November 23rd 2021, 5:11am
gnomikos1 @gnomikos1
RT @endpts: Eight months after Neurocrine $NBIX chronicled a flop for a mid-stage schizophrenia drug, the biotech is headed right back into…
November 23rd 2021, 5:11am
BioCentury @BioCentury
A new home: #Sosei finds a new partner for muscarinic agonist programs in $NBIX with better terms than its 2016 dea… https://t.co/sVCpFk8SqF
November 23rd 2021, 12:11am
Jarvis_Alerts @Jarvis_Alerts
$NBIX 60P Exp:20-May-22 ? ? Total(Day): $50,830 #UnusualActivity Sign-up free for beta ver.:… https://t.co/ex2M0YY1Ew
November 22nd 2021, 10:11pm
MarcJacksonLA @MarcJacksonLA
$NBIX Neurocrine stocks up on a biotech's psychiatric drugs https://t.co/H3zUCO5Z3A via @BioPharmaDive
November 22nd 2021, 9:11pm
newsfilterio @newsfilterio
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets $NBIX https://t.co/mzqupoATUB
November 22nd 2021, 5:11pm
mttsubu @mttsubu
RT @BentheFidler: Neurocrine stocks up on a biotech's psychiatric drugs https://t.co/crJtzCKI83 by @realJacobBell $NBIX
November 22nd 2021, 4:11pm
BentheFidler @BentheFidler
Neurocrine stocks up on a biotech's psychiatric drugs https://t.co/crJtzCKI83 by @realJacobBell $NBIX
November 22nd 2021, 4:11pm
endpts @endpts
Eight months after Neurocrine $NBIX chronicled a flop for a mid-stage schizophrenia drug, the biotech is headed rig… https://t.co/ufEkLlTUSC
November 22nd 2021, 3:11pm
MarcJacksonLA @MarcJacksonLA
$NBIX Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonist… https://t.co/tDBoXyNHhz
November 22nd 2021, 3:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.